One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Cardiometabolic HFpEF: NASH of the Heart.
Capone, Federico MD; Vettor, Roberto MD; Schiattarella, Gabriele G. MD, PhD
doi : 10.1161/CIRCULATIONAHA.122.062874
Volume 147(6) pgs. 451-518,e73-e75 February 07, 2023
Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial.
Ostadal, Petr MD, PhD; Rokyta, Richard MD, PhD; Karasek, Jiri MD, PhD; Kruger, Andreas MD, PhD; Vondrakova, Dagmar MD, PhD; Janotka, Marek MD; Naar, Jan MD, PhD; Smalcova, Jana MD; Hubatova, Marketa MSc; Hromadka, Milan MD, PhD; Volovar, Stefan MD; Seyfrydova, Miroslava MD; Jarkovsky, Jiri PhD; Svoboda, Michal MSc; Linhart, Ales MD, PhD; Belohlavek, Jan MD, PhD; for the ECMO-CS Investigators
doi : 10.1161/CIRCULATIONAHA.122.062949
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly being used for circulatory support in patients with cardiogenic shock, although the evidence supporting its use in this context remains insufficient.
Extracorporeal Membrane Oxygenation for Cardiogenic Shock: When to Open the Parachute?.
Henry, Timothy D. MD; Yannopoulos, Demetri MD; van Diepen, Sean MD, MSc
Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II.
Gyldenkerne, Christine MD; Maeng, Michael MD, PhD; Kjoller-Hansen, Lars DMSc; Maehara, Akiko MD; Zhou, Zhipeng MA; Ben-Yehuda, Ori MD; Erik Botker, Hans MD, PhD, DMSc; Engstrom, Thomas MD, PhD; Matsumura, Mitsuaki BS; Mintz, Gary S. MD; Frobert, Ole MD, PhD; Persson, Jonas MD, PhD; Wiseth, Rune MD, PhD; Larsen, Alf I. MD, PhD; Jensen, Lisette O. MD, PhD; Nordrehaug, Jan E. MD, PhD; Bleie, Oyvind MD, PhD; Omerovic, Elmir MD, PhD; Held, Claes MD, PhD; James, Stefan K. MD, PhD; Ali, Ziad A. MD, DPhil; Rosen, Hans C. BSc; Stone, Gregg W. MD; Erlinge, David MD, PhD
doi : 10.1161/CIRCULATIONAHA.122.061983
Patients with diabetes have increased rates of major adverse cardiac events (MACEs). We hypothesized that this is explained by diabetes-associated differences in coronary plaque morphology and lipid content.
The Effect of Lymphangiogenesis in Transplant Arteriosclerosis.
Chen, Kai MB; Mou, Rong MB; Zhu, Pengwei MB; Xu, Xiaodong MB; Wang, Han MSc; Jiang, Liujun PhD; Hu, Yanhua MD; Hu, Xiaosheng MD; Ma, Liang MD; Xiao, Qingzhong MD, PhD; Xu, Qingbo MD, PhD
doi : 10.1161/CIRCULATIONAHA.122.060799
Transplant arteriosclerosis is a major complication in long-term survivors of heart transplantation. Increased lymph flow from donor heart to host lymph nodes has been reported to play a role in transplant arteriosclerosis, but how lymphangiogenesis affects this process is unknown.
Novel Cardiokine GDF3 Predicts Adverse Fibrotic Remodeling After Myocardial Infarction.
Masurkar, Nihar PhD ,*; Bouvet, Marion PhD ,*; Logeart, Damien MD, PhD; Jouve, Charlene MSc; Drame, Fatou MSc; Claude, Olivier PhD; Roux, Maguelonne PhD; Delacroix, Clement PhD; Bergerot, Damien MSc; Mercadier, Jean-Jacques MD, PhD; Sirol, Marc MD, PhD; Gellen, Barnabas MD, PhD; Livrozet, Marine MD, PhD; Fayol, Antoine MD; Robidel, Estelle MSc; Tregouet, David-Alexandre PhD; Marazzi, Giovanna MD, PhD; Sassoon, David PhD; Valente, Mariana PhD; Hulot, Jean-Sebastien MD, PhD
doi : 10.1161/CIRCULATIONAHA.121.056272
Myocardial infarction (MI) induces a repair response that ultimately generates a stable fibrotic scar. Although the scar prevents cardiac rupture, an excessive profibrotic response impairs optimal recovery by promoting the development of noncontractile fibrotic areas.
No Benefit Seen for Nighttime Dosing Over Morning Dosing for Antihypertensive Medications.
Kuehn, Bridget M.
Stepwise Generation of Human Induced Pluripotent Stem Cell-Derived Cardiac Pericytes to Model Coronary Microvascular Dysfunction.
Shen, Mengcheng PhD ,,,*; Liu, Chun PhD ,,,*; Zhao, Shane Rui PhD; Manhas, Amit PhD; Sundaram, Laksshman PhD; Ameen, Mohamed PhD; Wu, Joseph C. MD, PhD
Letter by Sawami et al Regarding Article, "Effects of Early Empagliflozin Initiation on Diuresis and Kidney Function in Patients With Acute Decompensated Heart Failure (EMPAG-HF)".
Sawami, Kosuke MD; Tanaka, Atsushi MD, PhD; Node, Koichi MD, PhD
Response by Schulze et al to Letter Regarding Article, "Effects of Early Empagliflozin Initiation on Diuresis and Kidney Function in Patients With Acute Decompensated Heart Failure (EMPAG-HF)".
Schulze, P. Christian MD, PhD; Bogoviku, Jurgen MD; Westphal, Julian MD; Aftanski, Pawel MD; Haertel, Franz MD; Grund, Sissy MS; Haehling, Stephan von MD, PhD; Schumacher, Ulrike PhD; Mobius-Winkler, Sven MD, PhD; Busch, Martin MD
